Proteovant Therapeutics is a biotechnology company that utilizes protein degradation research in the development of medicines for diseases.

Biotechnology

Health Care

Pharmaceutical

Proteovant Therapeutics

Proteovant Therapeutics' headquarters in New York, NY, United States

Drew Fromkin

Ruby Holder

Zhihua Sui

Eric Venker

Frank Torti

Jonggil Choi

The Leadership Team at Proteovant Therapeutics consists of key executives and VPs who oversee the strategic direction and operational execution of the company’s initiatives. They focus on driving the company's mission to leverage protein degradation research for developing innovative treatments for various diseases, ensuring alignment across scientific discovery, program management, chemistry, biology, molecular technology, and manufacturing processes.

Leadership Team

The Vice Presidents at Proteovant Therapeutics lead their respective departments—Biology, Discovery Chemistry, CMC (Chemistry, Manufacturing, and Controls), DMPK (Drug Metabolism and Pharmacokinetics), Molecular Technology, and Program Management. They ensure strategic alignment and operational excellence in their fields, driving the development of innovative protein degradation therapies for disease treatment.

Proteovant Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Vice Presidents

Offices

Proteovant Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Vice Presidents

Offices

Related companies